All In Biotech

Drug Trial Radar · NCT03467958

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

A Phase 3, Multicenter, Open-Label Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

Last checked: Nov 20, 2026Latest source record: Sep 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

854

Actual

Start

Aug 24, 2018

Primary completion

Oct 31, 2024

Study completion Oct 31, 2024

Sponsor

Lead sponsor
CelgeneBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Mar 16, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an extension study to evaluate safety and efficacy of ozanimod in participants with moderately to severely active Crohn's Disease.

Conditions

  • Crohn Disease

Interventions

  • OzanimodDrug

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Clinical RemissionTime frame: At weeks 48, 96, 144, 192, 240
  2. Number of Participants With Treatment Emergent Adverse Events (TEAEs)Time frame: From first dose to 90 days post last dose (up to approximately an average of 19 months and a maximum of 65 months)

Locations

766 sites in 49 countries. Site status is shown where the registry gives one.

  • Holland Center for Family Health

    Peoria, Arizona

  • Local Institution - 202

    Scottsdale, Arizona

  • Local Institution - 026

    North Little Rock, Arkansas

  • Local Institution - 284

    Camarillo, California

  • Sharp Chula Vista Medical Center

    Chula Vista, California

  • Local Institution - 039

    Garden Grove, California

  • Ucsd Medical Center

    La Jolla, California

  • San Diego Clinical Trials

    La Mesa, California

  • Local Institution - 010

    Lancaster, California

  • Local Institution - 061

    Los Angeles, California

  • Southern California Research Institute Medical Group, Inc.

    Los Angeles, California

  • Matrix Clinical Research Inc

    Los Angeles, California

  • Local Institution - 110

    Los Angeles, California

  • Facey Medical Foundation (Parent)

    Mission Hills, California

  • ABS Health, LLC

    Mission Viejo, California

  • Alliance Clinical Research

    Oceanside, California

  • Local Institution - 027

    Orange, California

  • Palo Alto Center-Palo Alto Medical Foundation Research Institute

    Palo Alto, California

  • Havana Research Institute LLC

    Pasadena, California

  • Local Institution - 006

    Rialto, California

  • Sutter Medical Group

    Roseville, California

  • Local Institution - 280

    Sacramento, California

  • Local Institution - 003

    San Diego, California

  • Local Institution - 281

    San Francisco, California

  • New Hope Research Development

    West Covina, California

  • Local Institution - 065

    Colorado Springs, Colorado

  • Local Institution - 297

    Lakewood, Colorado

  • Local Institution - 182

    Bristol, Connecticut

  • Local Institution - 225

    Bristol, Connecticut

  • Local Institution - 091

    New Haven, Connecticut

  • Local Institution - 062

    Clearwater, Florida

  • Clinical Research of West Florida

    Clearwater, Florida

  • South Lake Pain Institute

    Clermont, Florida

  • American Research Institute Inc

    Cutler Bay, Florida

  • Local Institution - 112

    Doral, Florida

  • Riverside Clinical Research

    Edgewater, Florida

  • Local Institution - 218

    Gainesville, Florida

  • Local Institution - 203

    Hialeah, Florida

  • Floridian Clinical Research LLC

    Hialeah, Florida

  • Harmony Medical Research Institute

    Hialeah, Florida

Showing 40 of 766 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.